INDV Indivior Pharmaceuticals, Inc. - 8-K

Item 8.01 Other Events.

On March 12, 2026, the Company announced the pricing of its offering of 0.625% convertible senior notes due 2031 (the “Notes”). A copy of the press release is filed as 99.1 to this Current Report on Form 8-K.

Neither this Current Report on Form 8-K nor the press release constitutes an offer to sell, or the solicitation of an offer to buy, the Notes or the shares of the Company’s common stock, if any, issuable upon conversion of the Notes.

Item 9.01 Exhibits

(d) Exhibits.

Exhibit No.

Description

99.1

Press release dated March 12, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)